Rankings
▼
Calendar
JAZZ FY 2022 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena
JAZZ
Jazz Pharmaceuticals plc
$12B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3.7B
+18.3% YoY
Gross Profit
$3.1B
85.2% margin
Operating Income
-$66M
-1.8% margin
Net Income
-$224M
-6.1% margin
EPS (Diluted)
$-3.58
Cash Flow
Operating Cash Flow
$1.3B
Free Cash Flow
$774M
Stock-Based Comp.
$222M
Balance Sheet
Total Assets
$10.8B
Total Liabilities
$7.7B
Stockholders' Equity
$3.1B
Cash & Equivalents
$881M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.7B
$3.1B
+18.3%
Gross Profit
$3.1B
$2.7B
+17.5%
Operating Income
-$66M
$170M
-138.5%
Net Income
-$224M
-$329M
+31.9%
← Q4 2021
All Quarters
Q1 2022 →